Safety and Efficacy Evaluation of AIV001 in Nonmelanoma Skin Cancer of the Low Risk Basal Cell Carcinoma Subtype

Clinical trial NCT04470726 · COMPLETED

Trial details

NCT number: NCT04470726
Sponsor: AiViva BioPharma, Inc.
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Superficial Basal Cell Carcinoma Nodular Basal Cell Carcinoma Nonmelanoma Skin Cancers

Start date: 2020-08-18
Primary completion: 2023-06-20
Enrollment: 26

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.